Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 47,085 | 43,237 | 43,745 | 36,821 | 35,855 |
| Operating Income | -47,085 | -43,237 | -43,745 | -36,821 | -35,855 |
| Other Income | 3,009 | 4,650 | 4,127 | 1,759 | 928 |
| Pre-tax Income | -44,076 | -38,587 | -39,618 | -35,062 | -34,927 |
| Net Income Continuous | -44,076 | -38,587 | -39,618 | -35,062 | -34,927 |
| Net Income | $-44,076 | $-38,587 | $-39,618 | $-35,062 | $-34,927 |
| EPS Basic Total Ops | -0.59 | -0.55 | 0.16 | -0.50 | -0.71 |
| EPS Basic Continuous Ops | -0.59 | -0.55 | -0.50 | -0.50 | -0.71 |
| EPS Diluted Total Ops | -0.59 | -0.55 | 0.16 | -0.50 | -0.71 |
| EPS Diluted Continuous Ops | -0.59 | -0.55 | -0.50 | -0.50 | -0.71 |
| EBITDA(a) | $-47,260 | $-43,751 | $-44,507 | $-37,021 | $-35,758 |